Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Journal of Clinical Pathology|February 26, 2013
Ki67 and proliferation in breast cancerNirmala Pathmanathan, Rosemary L Balleine
ANZ Journal of Surgery|January 22, 2003
Targeting molecular mechanisms in cancerRosemary L Balleine, Richard F Kefford
Molecular Diagnosis & Therapy|July 21, 2012
High-risk estrogen-receptor-positive breast cancer: identification and implications for therapyRosemary L Balleine, Nicholas R Wilcken
The American Journal of Surgical Pathology|October 26, 2006
Morphology of breast cancer as a means of triage of patients for BRCA1 genetic testingGelareh Farshid, Rosemary L Balleine, Margaret Cummings, et al.
Pathology|May 1, 2008
Histopathological features of 'BRCAX' familial breast cancers in the kConFab resourceMaurice Loughrey, Pamela J Provan, Karen Byth, et al.
Cell and Tissue Banking|February 19, 2011
Development of a data entry auditing protocol and quality assurance for a tissue bank databaseMatloob Khushi, Jane E Carpenter, Rosemary L Balleine, et al.
Biopreservation and Biobanking|May 23, 2014
Electronic biorepository application system: web-based software to manage receipt, peer review, and approval of researcher applications to a biobankMatloob Khushi, Jane E Carpenter, Rosemary L Balleine, et al.
Breast Cancer Research and Treatment|June 24, 2011
HER2 discordance between primary breast cancer and its paired metastasis: tumor biology or test artefact? Insights through meta-analysisNehmat Houssami, Petra Macaskill, Rosemary L Balleine, et al.
Endocrine-Related Cancer|October 12, 2021
New therapeutic opportunities for women with low-grade serous ovarian cancerTania Moujaber, Rosemary L Balleine, Bo Gao, et al.
Clinical Pharmacology and Therapeutics|June 5, 2004
CYP3A5 genotype and midazolam clearance in Australian patients receiving chemotherapyMark Wong, Rosemary L Balleine, Michael Collins, et al.
Pageof 5